MATHEWS CHARLES 4
4 · AVANIR PHARMACEUTICALS, INC. · Filed Mar 7, 2012
Insider Transaction Report
Form 4
MATHEWS CHARLES
Director
Transactions
- Purchase
Common Stock
2012-03-06$2.69/sh+5,000$13,473→ 5,000 total(indirect: By Trust)
Holdings
- 1,875(indirect: By Individual Retirement Account)
Common Stock
- 270,094
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.68 to $2.6993, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Consists of (i) 267,594 shares underlying restricted stock units granted under the Issuer's equity plans, and (ii) 2,500 shares of common stock held by Mr. Mathews.